Nonclinical Safety Assessment

A Guide to International Pharmaceutical Regulations

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Nonclinical Safety Assessment by , Wiley
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781118516980
Publisher: Wiley Publication: March 5, 2013
Imprint: Wiley Language: English
Author:
ISBN: 9781118516980
Publisher: Wiley
Publication: March 5, 2013
Imprint: Wiley
Language: English

Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty years, while necessary, has only served to amplify these costs. In response to this escalation, developmental strategies have shifted towards a more global approach. In order to create the most cost-effective and safe processes, it is critical for those bringing drugs to market to understand both the globally accepted regulations and the local variations. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations provides a practical description of nonclinical drug development regulations and requirements in the major market regions.

It includes:

  • ICH – the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
  • National regulations, including US FDA, Canada, Mercosur and Brazil, South Africa, China, Japan, India and Australia
  • Repeated dose toxicity studies
  • Carcinogenicity; Genotoxicity; Developmental and reproductive toxicology; Immunotoxicology
  • Biotechnology-derived pharmaceuticals
  • Vaccine development
  • Phototoxicity and photocarcinogenicity
  • Degradants, impurities, excipients and metabolites

Primarily intended for those professionals actively involved in the nonclinical and clinical development of a pharmaceutical product, including toxicologists, pharmacologists, clinicians and project managers, this book provides a roadmap for successful new drug approval and marketing*.*

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty years, while necessary, has only served to amplify these costs. In response to this escalation, developmental strategies have shifted towards a more global approach. In order to create the most cost-effective and safe processes, it is critical for those bringing drugs to market to understand both the globally accepted regulations and the local variations. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations provides a practical description of nonclinical drug development regulations and requirements in the major market regions.

It includes:

Primarily intended for those professionals actively involved in the nonclinical and clinical development of a pharmaceutical product, including toxicologists, pharmacologists, clinicians and project managers, this book provides a roadmap for successful new drug approval and marketing*.*

More books from Wiley

Cover of the book Risk Management in Student Affairs by
Cover of the book The Power to Compete by
Cover of the book Risk Management by
Cover of the book C. S. Lewis by
Cover of the book Social Movements in Times of Austerity: Bringing Capitalism Back Into Protest Analysis by
Cover of the book Law and Ethics in Children's Nursing by
Cover of the book Developing Core Literacy Proficiencies, Grade 7 by
Cover of the book Raising Capital For Dummies by
Cover of the book Is Inequality in America Irreversible? by
Cover of the book Yoga - Philosophy for Everyone by
Cover of the book Plant-Based Natural Products by
Cover of the book The New Form 990 by
Cover of the book Troubleshooting and Maintaining Your PC All-in-One For Dummies by
Cover of the book Blind Spots by
Cover of the book Mergers and Acquisitions Basics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy